K. Alper, H. Lotsof, G. Frenken, D. Luciano, and J. Bastiaans, Ibogaine in Acute Opioid Withdrawal: An Open Label Case Series, Annals of the New York Academy of Sciences, vol.909, issue.1, pp.257-259, 2000.
DOI : 10.1111/j.1749-6632.2000.tb06687.x

K. Alper, H. Lotsof, and C. Kaplan, The ibogaine medical subculture, Journal of Ethnopharmacology, vol.115, issue.1, pp.9-24, 2008.
DOI : 10.1016/j.jep.2007.08.034

B. Badio, W. Padgett, and J. Daly, Ibogaine: a potent noncompetitive blocker of ganglionic/neuronal nicotinic receptors, Mol Pharmacol, vol.51, pp.1-5, 1997.

M. Baumann, R. Rothman, J. Pablo, and D. Mash, In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, p.12, 2001.

S. Cappendijk and M. Dzoljic, Inhibitory effects of ibogaine on cocaine self-administration in rats, European Journal of Pharmacology, vol.241, issue.2-3, pp.261-265, 1993.
DOI : 10.1016/0014-2999(93)90212-Z

S. Cappendijk, D. Fekkes, and M. Dzoljic, The inhibitory effect of norharman on morphine withdrawal syndrome in rats: Comparison with ibogaine, Behavioural Brain Research, vol.65, issue.1, pp.117-119, 1994.
DOI : 10.1016/0166-4328(94)90080-9

S. Carnicella, S. Ahmadiantehrani, D. He, C. Nielsen, S. Bartlett et al., Cabergoline Decreases Alcohol Drinking and Seeking Behaviors Via Glial Cell Line-Derived Neurotrophic Factor, Biological Psychiatry, vol.66, issue.2, pp.146-153, 2009.
DOI : 10.1016/j.biopsych.2008.12.022
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895406

S. Carnicella, R. Amamoto, and R. D. , Excessive alcohol consumption is blocked by glial cell line???derived neurotrophic factor, Alcohol, vol.43, issue.1, pp.35-43, 2009.
DOI : 10.1016/j.alcohol.2008.12.001
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789656